hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
2.4 KEY PERFORMANCE INDICATORS AND PERFORMANCE HIGHLIGHTS
The following key performance indicators are closely monitored to ensure that business strategies and objectives are closely aligned with shareholder value creation. The key performance indicators are not measurements in accordance with IFRS and should not be considered an alternative to other measures of performance in accordance with IFRS. The Corporation's method of calculating key performance indicators may differ from other companies and, accordingly, these key performance indicators may not be comparable to similar measures presented by other companies. The Corporation measures its performance, with regard to these objectives by monitoring revenue, adjusted EBITDA(1), free cash flow(1) and capital intensity(1) on a constant currency basis(1).
(1) Fiscal 2018 was restated to comply with IFRS 15 and to reflect a change in accounting policy as well as to reclassify results from Cogeco Peer 1 as discontinued operations. For further details, please consult the "Accounting policies" and "Discontinued operations" sections.
(2) Following the announcement of the agreement on February 27, 2019 to sell Cogeco Peer 1, fiscal 2019 financial guidelines were revised.
(3) Actual results are presented in constant currency based on fiscal 2018 average foreign exchange rates of 1.2773 USD/CDN.
For further details on the Corporation's operating results, please refer to the "Operating and financial results", the "Segmented operating and financial results" and the "Cash flow analysis" sections.
Table:
(in millions of dollars, except percentages) | Actual Fiscal 2018 (1) $ | Revised projections (2) Fiscal 2019 (constant currency) (3) | Actual Fiscal 2019 (constant currency) (3) $ | Actual Fiscal 2019 (constant currency) (3) % | Achievement of the projections Fiscal 2019
Financial guidelines |  |  |  |  | 
Revenue | 2,147 | Increase of 6% to 8% | 2,294 | 6.8 | Achieved
Adjusted EBITDA | 1,007 | Increase of 8% to 10% | 1,092 | 8.5 | Achieved
Acquisitions of property, plant and equipment | 458 | $450 to $470 | 425 | (7.1) | Surpassed
Capital intensity | 21.3% | 20% to 21% | 18.5% | - | Surpassed
Free cash flow | 302 | Increase of 38% to 45% | 453 | 50.0 | Surpassed


Question: What was the increase / (decrease) in Free Cash flow from 2018 to 2019?
Answer: 151
Calculation: 453 - 302
Backlog
As reflected in the table above, total backlog decreased $663.5 million from September 30, 2018 to September 30, 2019. The decrease in backlog is primarily due to progression of work in 2019 on four large contracts awarded to CTS in fiscal 2018. In addition, we recorded a net decrease to backlog of $104.5 million on October 1, 2018 for the impact of the adoption of ASC 606. Changes in exchange rates between the prevailing currency in our foreign operations and the U.S. dollar as of September 30, 2019 decreased backlog by $79.7 million compared to September 30, 2018.
Table:
 | September 30,    | September 30,    
 | 2019 | 2018
 |  | (in millions)   
Total backlog     |  | 
Cubic Transportation Systems | $  2,953.3 | $  3,544.9
Cubic Mission Solutions | 103.7 | 77.0
Cubic Global Defense | 344.0 | 442.6
Total   | $  3,401.0 | $  4,064.5


Question: What led to the decrease in backlog?
Answer: primarily due to progression of work in 2019 on four large contracts awarded to CTS in fiscal 2018, impact of the adoption of ASC 606
Revenue
We manage our business on a geographic basis, organized into three geographic segments. Our revenue, which includes product and service for each segment, is summarized in the following table (in millions, except percentages):
Amounts may not sum and percentages may not recalculate due to rounding.
Total revenue in fiscal 2019 increased by 5% compared with fiscal 2018. Product revenue increased by 6% and service revenue increased by 2%. Our total revenue reflected growth across each of our geographic segments. Product revenue for the BRICM countries, in the aggregate, experienced 1% product revenue decline, driven by a 16% decrease in product revenue in China and a decrease of 1% in Brazil. These decreases were partially offset by increased product revenue in Mexico, Russia and India of 26%, 6% and 5%, respectively.
In addition to the impact of macroeconomic factors, including a reduced IT spending environment and reductions in spending by government entities, revenue by segment in a particular period may be significantly impacted by several factors related to revenue recognition, including the complexity of transactions such as multiple performance obligations; the mix of financing arrangements provided to channel partners and customers; and final acceptance of the product, system, or solution, among other factors. In addition, certain customers tend to make large and sporadic purchases, and the revenue related to these transactions may also be affected by the timing of revenue recognition, which in turn would impact the revenue of the relevant segment.
Table:
 |  | Years Ended |  | 2019 vs. 2018 | 
 | July 27, 2019 | July 28, 2018 | July 29, 2017 | Variance in Dollars | Variance in Percent
Revenue: |  |  |  |  | 
Americas | $ 30,927 | $ 29,070 | $28,351 | $1,857 | 6%
Percentage of revenue | 59.6% | 58.9% | 59.1% |  | 
EMEA | 13,100 | 12,425 | 12,004 | 675 | 5%
Percentage of revenue | 25.2% | 25.2% | 25.0% |  | 
APJC | 7,877 | 7,834 | 7,650 | 43 | 1%
Percentage of revenue | 15.2% | 15.9% | 15.9% |  | 
Total | $51,904 | $49,330 | $48,005 | $2,574 | 5%


Question: What was the revenue from Americas in 2019?
Answer: 30,927
Stock-based Compensation Expense
The following table sets forth our stock-based compensation expense for the years ended December 31, 2019, 2018 and 2017 (in thousands):
Stock-based compensation awards include employee stock options, restricted stock awards and units, and employee stock purchases. For the year ended December 31, 2019, stock-based compensation expense was $31.6 million, of which $0.2 million related to employee stock options, $29.1 million related to restricted stock awards and units and $2.3 million related to employee stock purchases. For the year ended December 31, 2018, stock-based compensation expense was $31.0 million, of which $0.4 million related to employee stock options, $28.0 million related to restricted stock awards and units and $2.6 million related to employee stock purchases. The increase in stock-based compensation expense in 2019 compared to 2018 was due primarily to a higher volume of restricted stock unit grants.
Table:
 |  | Years Ended December 31, | 
 | 2019 | 2018 | 2017
Research, development and other related costs | $14,643 | $13,168 | $13,277
Selling, general and administrative | 16,911 | 17,843 | 20,185
Total stock-based compensation expense | $31,554 | $31,011 | $33,462


Question: What is the overall proportion of employee stock options and employee stock purchases over total stock-based compensation expense in 2019?
Answer: 0.08
Calculation: (0.2+2.3)/31.6
Common Stock Outstanding
The following represents the common stock outstanding for the fiscal year ended:
(1) During fiscal years 2018, 2017 and 2016, the Company’s Board of Directors authorized the repurchase of $350.0 million, $450.0 million and $400.0 million, respectively, of the Company’s common stock under share repurchase programs, which were repurchased during fiscal years 2019, 2018 and 2017, respectively.
Table:
 |  | Fiscal Year Ended August 31, | 
 | 2019 | 2018 | 2017
Common stock outstanding: |  |  | 
Beginning balances | 164,588,172 | 177,727,653 | 186,998,472
Shares issued upon exercise of stock options | 11,348 | 30,832 | 172,620
Shares issued under employee stock purchase plan | 1,282,042 | 1,105,400 | 1,228,316
Vesting of restricted stock | 1,983,261 | 2,727,229 | 2,102,049
Purchases of treasury stock under employee stock plans | (489,836) | (793,052) | (550,096)
Treasury shares purchased(1) | (13,854,607) | (16,209,890) | (12,223,708)
Ending balances | 153,520,380 | 164,588,172 | 177,727,653


Question: What was the Beginning balance in 2019?
Answer: 164,588,172
equity compensation plan information the following table presents the equity securities available for issuance under our equity compensation plans as of december 31 , 2015 . equity compensation plan information plan category number of securities to be issued upon exercise of outstanding options , warrants and rights ( 1 ) weighted-average exercise price of outstanding options , warrants and rights ( 2 ) number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( a ) ( b ) ( c ) equity compensation plans approved by security holders 1424356 $ 33.90 4281952 equity compensation plans not approved by security holders ( 3 ) 2014 2014 2014 .

Table:
plan category | number of securities to be issued upon exercise of outstanding options warrants and rights ( 1 ) ( a ) ( b ) | weighted-average exercise price of outstanding optionswarrants and rights ( 2 ) | number of securities remaining available for future issuance under equity compensation plans ( excluding securitiesreflected in column ( a ) ) ( c )
equity compensation plans approved by security holders | 1424356 | $ 33.90 | 4281952
equity compensation plans not approved by security holders ( 3 ) | 2014 | 2014 | 2014
total | 1424356 | $ 33.90 | 4281952
( 1 ) includes grants made under the huntington ingalls industries , inc .
2012 long-term incentive stock plan ( the "2012 plan" ) , which was approved by our stockholders on may 2 , 2012 , and the huntington ingalls industries , inc .
2011 long-term incentive stock plan ( the "2011 plan" ) , which was approved by the sole stockholder of hii prior to its spin-off from northrop grumman corporation .
of these shares , 533397 were subject to stock options and 54191 were stock rights granted under the 2011 plan .
in addition , this number includes 35553 stock rights , 10279 restricted stock rights , and 790936 restricted performance stock rights granted under the 2012 plan , assuming target performance achievement .
( 2 ) this is the weighted average exercise price of the 533397 outstanding stock options only .
( 3 ) there are no awards made under plans not approved by security holders .
item 13 .
certain relationships and related transactions , and director independence information as to certain relationships and related transactions and director independence will be incorporated herein by reference to the proxy statement for our 2016 annual meeting of stockholders , to be filed within 120 days after the end of the company 2019s fiscal year .
item 14 .
principal accountant fees and services information as to principal accountant fees and services will be incorporated herein by reference to the proxy statement for our 2016 annual meeting of stockholders , to be filed within 120 days after the end of the company 2019s fiscal year. .

Question: what portion of the equity compensation plans approved by security holders remains available for future issuance?
Answer: 75.0%
Calculation: add(1424356, 4281952), divide(4281952, #0)
Sales and Marketing
Sales and marketing expenses in 2019 decreased by $7.6 million, or 32%, as compared to 2018. This decrease was primarily due to a reduction in the global sales support and marketing headcount, including reductions that were part of our restructuring activities during 2019 (refer to Note 4 of the accompanying consolidated financial statements), contributing to net decreases of $4.8 million in personnel-related costs, and $1.0 million in allocated facilities and information technology costs as compared to 2018. Restructuring costs in 2019 decreased $0.4 million, as there were additional restructuring activities in 2018, including a headcount reduction of approximately 13% of our workforce and the closure of certain leased facilities. The remaining decrease during 2019 was primarily the result of lower marketing costs of $0.6 million, as we eliminated or shifted the timing of certain of our marketing activities.
Table:
 | Years Ended December 31, |  | Change | 
 | 2019 | 2018 | $ | %
 | (dollars in thousands) |  |  | 
Sales and marketing | $15,836 | $23,425 | $(7,589) | (32)%
Percent of revenues, net | 32% | 40% |  | 


Question: What is the value of the change between 2018 and 2019's sales and marketing expenses as a percentage of the 2018 sales and marketing expenses?
Answer: 32.4
Calculation: 7,589/23,425
sources and uses of cash ( in millions ) in summary , our cash flows for each period were as follows : years ended ( in millions ) dec 29 , dec 30 , dec 31 .

Table:
years ended ( in millions ) | dec 292018 | dec 302017 | dec 312016
net cash provided by operating activities | $ 29432 | $ 22110 | $ 21808
net cash used for investing activities | -11239 ( 11239 ) | -15762 ( 15762 ) | -25817 ( 25817 )
net cash provided by ( used for ) financing activities | -18607 ( 18607 ) | -8475 ( 8475 ) | -5739 ( 5739 )
net increase ( decrease ) in cash and cash equivalents | $ -414 ( 414 ) | $ -2127 ( 2127 ) | $ -9748 ( 9748 )
md&a consolidated results and analysis 40 .

Question: what was the percentage change in net cash provided by operating activities between 2017 and 2018?
Answer: 33%
Calculation: subtract(29432, 22110), divide(#0, 22110)
The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, China, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa, or EMEA markets and North American markets.
Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill, by geographic area are as follows (in thousands):
(1) Amounts do not include leased right-of-use assets in the prior period due to the adoption of ASC 842 under the modified retrospective method with a cumulative effect adjustment to accumulated deficit as of January 1, 2019.
Table:
 | As of December 31, |  |  | 
 | 2019 |  | 2018(1) | 
 | Amount | % of total | Amount | % of total
United States | $385,302 | 85% | $426,321 | 85%
Singapore | 63,556 | 14% | 71,945 | 14%
Rest of world | 5,034 | 1% | 3,368 | 1%
Total | $453,892 | 100% | $501,634 | 100%


Question: What was the percentage of total from Singapore in 2019?
Answer: 14
Uncertain Tax Positions
As of June 30, 2019, 2018, and 2017, we had accrued interest expense related to uncertain tax positions of $3.4 billion, $3.0 billion, and $2.3 billion, respectively, net of income tax benefits. The provision for (benefit from) income taxes for fiscal years 2019, 2018, and 2017 included interest expense related to uncertain tax positions of $515 million, $688 million, and $399 million, respectively, net of income tax benefits.
The aggregate changes in the gross unrecognized tax benefits related to uncertain tax positions were as follows:
We settled a portion of the Internal Revenue Service (“IRS”) audit for tax years 2004 to 2006 in fiscal year 2011. In February 2012, the IRS withdrew its 2011 Revenue Agents Report related to unresolved issues for tax years 2004 to 2006 and reopened the audit phase of the examination. We also settled a portion of the IRS audit for tax years 2007 to 2009 in fiscal year 2016, and a portion of the IRS audit for tax years 2010 to 2013 in fiscal year 2018. We remain under audit for tax years 2004 to 2013. We expect the IRS to begin an examination of tax years 2014 to 2017 within the next 12 months.
As of June 30, 2019, the primary unresolved issues for the IRS audits relate to transfer pricing, which could have a material impact on our consolidated financial statements when the matters are resolved. We believe our allowances for income tax contingencies are adequate. We have not received a proposed assessment for the unresolved issues and do not expect a final resolution of these issues in the next 12 months. Based on the information currently available, we do not anticipate a significant increase or decrease to our tax contingencies for these issues within the next 12 months.
We are subject to income tax in many jurisdictions outside the U.S. Our operations in certain jurisdictions remain subject to examination for tax years 1996 to 2018, some of which are currently under audit by local tax authorities. The resolution of each of these audits is not expected to be material to our consolidated financial statements.
Table:
(In millions) |  |  | 
Year Ended June 30, | 2019 | 2018 | 2017
Beginning unrecognized tax benefits | $ 11,961 | $ 11,737 | $ 10,164
Decreases related to settlements | (316) | (193) | (4)
Increases for tax positions related to the current year | 2,106 | 1,445 | 1,277
Increases for tax positions related to prior years | 508 | 151 | 397
Decreases for tax positions related to prior years | (1,113) | (1,176) | (49)
Decreases due to lapsed statutes of limitations | 0 | (3) | (48)
Ending unrecognized tax benefits | $  13,146 | $  11,961 | $  11,737


Question: Which of the 3 years had the highest ending unrecognized tax benefits?
Answer: 2019
Calculation: 13,146 > 11,961 > 11,737
DEVELOPMENT OF EMPLOYEE NUMBERS BY SEGMENTS
By headcount1 as of closing date of 30/9
1 Excluding METRO China.
Table:
 | 2018 | 2019
METRO | 92,603 | 89,574
METRO Germany | 13,711 | 13,606
METRO Western Europe (excl.Germany) | 27,207 | 27,227
METRO Russia | 13,960 | 12,357
METRO Eastern Europe (excl.Russia) | 29,060 | 28,375
METRO Asia | 8,665 | 8,009
Others | 7,008 | 7,152
METROAG | 909 | 880
Total | 100,520 | 97,606


Question: What was the change in METRO AG headcount in 2019 from 2018?
Answer: -29
Calculation: 880-909
MARKET PRICES OF COMMON STOCK
The common stock of the Company is listed on the NASDAQ Global Market under the symbol “FEIM.”
Table:
Fiscal Quarter | High Sale | Low Sale
2019 |  | 
First Quarter | $8.95 | $7.30
Second Quarter | 11.38 | 7.80
Third Quarter | 13.38 | 9.60
Fourth Quarter | 13.52 | 10.80
2018 |  | 
First Quarter | $10.76 | $ 7.91
Second Quarter | 10.00 | 7.53
Third Quarter | 9.94 | 8.66
Fourth Quarter | 10.59 | 8.55


Question: Which global market is the common stock of the Company listed on?
Answer: NASDAQ
Total Shareholder Return Awards
During the years ended December 31, 2019, 2018, and 2017, pursuant to the 2016 Incentive Plan, the Company granted total shareholder return awards (“TSRs”). TSRs are performance shares that are earned, if at all, based upon the Company’s total shareholder return as compared to a group of peer companies over a three-year performance period. The award payout can range from 0% to 200%. To determine the grant date fair value of the TSRs, a Monte Carlo simulation model is used. The Company recognizes compensation expense for the TSRs over a three-year performance period based on the grant date fair value.
The grant date fair value of the TSRs was estimated using the following weighted-average assumptions:
Table:
 |  | Years Ended December 31, | 
 | 2019 | 2018 | 2017
Expected life (years) | 2.8 | 2.9 | 2.9
Interest rate | 2.5% | 2.4% | 1.5%
Volatility | 29.3% | 28.0% | 26.5%
Expected dividend yield | — | — | —


Question: What was the interest rate in 2017?
Answer: 1.5%
4. Cash and Cash Equivalents
The following table summarizes the components of our cash and cash equivalents (amounts in millions):
Table:
 | At December 31, | 
 | 2019 | 2018
Cash | $437 | $268
Foreign government treasury bills | 37 | 32
Money market funds | 5,320 | 3,925
Cash and cash equivalents | $5,794 | $4,225


Question: What was the percentage change in cash and cash equivalents between 2018 and 2019?
Answer: 37.14
Calculation: ($5,794-$4,225)/$4,225
Note 15. NET INCOME (LOSS) PER SHARE
We calculate basic net income (loss) per share by dividing earnings allocated to common stockholders by the basic weighted-average number of common shares outstanding for the period.
Diluted weighted-average shares is computed using basic weighted-average number of common shares outstanding plus any potentially dilutive securities outstanding during the period using the treasury-stock-type method and the if-converted method, except when their effect is anti-dilutive. Potentially dilutive securities include stock options, restricted stock units, and the outstanding senior convertible debentures.
The following table presents the calculation of basic and diluted net income (loss) per share attributable to stockholders:
1 As a result of our net loss attributable to stockholders for fiscal 2019, 2018, and 2017, the inclusion of all potentially dilutive stock options, restricted stock units, and common shares under noted warrants and convertible debt would be anti-dilutive. Therefore, those stock options, restricted stock units and shares were excluded from the computation of the weighted-average shares for diluted net loss per share for such periods.
Table:
 |  | Fiscal Year Ended | 
(In thousands, except per share amounts) | December 29, 2019 | December 30, 2018 | December 31, 2017
Basic net income (loss) per share: |  |  | 
Numerator: |  |  | 
Net income (loss) attributable to stockholders | $22,159 | $(811,091) | $(929,121)
Denominator: |  |  | 
Basic weighted-average common shares | 144,796 | 140,825 | 139,370
Basic net income (loss) per share | $0.15 | $(5.76) | $(6.67)
Diluted net income (loss) per share 1 |  |  | 
Numerator: |  |  | 
Net income (loss) attributable to stockholders | $22,159 | $(811,091) | $(929,121)
Net income (loss) available to common stockholders | $22,159 | $(811,091) | $(929,121)
Denominator: |  |  | 
Basic weighted-average common shares | 144,796 | 140,825 | 139,370
Effect of dilutive securities: |  |  | 
Restricted stock units | 2,729 | - | -
Dilutive weighted-average common shares: | 147,525 | 140,825 | 139,370
Dilutive net income (loss) per share | $ 0.15 | $ (5.76) | $ (6.67)


Question: What is the change in dilutive weighted-average common shares from 2018 to 2019?
Answer: 6700
Calculation: 147,525 - 140,825
15. Revenue from Contracts with Customers
Impact of Adopting Topic 606
The effects of the adoption on the Company's Consolidated Financial Statements for the fiscal year ended September 28, 2019 was as follows (in thousands):
Table:
 | September 28, 2019
As Reported | Adjustments due to Topic 606 | September 28, 2019
As Adjusted - Without
Adoption of Topic 606
ASSETS |  |  | 
   Contract assets | $90,841 | $90,841 | $—
Inventories | 700,938 | (81,895) | 782,833
LIABILITIES AND SHAREHOLDERS' EQUITY |  |  | 
Other accrued liabilities | $106,461 | $(375) | $106,836
Retained earnings | 1,178,677 | 9,321 | 1,169,356


Question: What was the difference between the balance before adjustment for Retained earnings and Other accrued liabilities?
Answer: 1072216
Calculation: 1,178,677-106,461
20 Trade and Other Receivables
Trade receivables are non interest-bearing and are generally on 30–90 day payment terms depending on the geographical territory in which sales are generated. The carrying value of trade and other receivables also represents their fair value. During the year-ended 31 March 2019 a provision for impairment of $0.6M (2018: $0.6M) was recognised in operating expenses against receivables.
The net contract acquisition expense deferred within the Consolidated Statement of Profit or Loss was $0.9M of the total $259.9M of Sales and Marketing costs (2018: $8.4M / $239.9M).
Table:
 | 31 March 2019 | 31 March 2018 Restated See note 2
 | $M | $M
Current |  | 
Trade receivables | 128.7 | 151.8
Prepayments | 26.9 | 23.1
Deferral of contract acquisition costs | 31.5 | 29.5
Other receivables | 8.2 | 6.4
Total current trade and other receivables | 195.3 | 210.8
Non-current |  | 
Deferral of contract acquisition costs | 15.1 | 16.2
Other receivables | 1.3 | 1.3
Total non-current trade and other receivables | 16.4 | 17.5


Question: In which year was the amount of Prepayments larger?
Answer: 2019
Calculation: 26.9>23.1